Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF | V.TLT.W

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > CGON 35% 12 months CR?

<< Previous

Bullboard Posts

Next >>

Comment by StevenBirchon May 03, 2024 6:36pm

191 Views

Post# 36022659

RE:RE:RE:CGON 35% 12 months CR?

It seems as if you're almost waiting in line with so many ongoing trials, let's hope TLT is next in line! Maybe these perceived 'delays' have nothing to do with TLT, that may upset some people.

Yajne wrote: Thanks for posting Eogan! I also found slide 16 "collaborators" interesting, includes some familiar names...Peter Black (UBC), Neal Shore (Carolina), Ashish Kamat (MD Anderson). With multiple trials happening for these guys, I always wonder how much priority Ruvidar gets at its clinical study sites

<< Previous

Bullboard Posts

Next >>

Advancing an underexplored area of the Yukon with the same geology as B.C’.s Golden Triangle